Funding for this research was provided by:
Reckitt Benckiser Pharmaceuticals
Consumer Health Products Association Pediatric Cough and Cold Task Group
Received: 19 May 2022
Accepted: 10 January 2023
First Online: 25 January 2023
: This study was conducted in accordance with the Declaration of Helsinki, and it complied with International Conference of Harmonisation (ICH) Good Clinical Practice (GCP) requirements. Ethical approval was provided by Schulman IRB in the US (protocol number RBNI US 1501).
: Freely given, signed, and dated written informed consent was obtained for all participants before they were asked to perform any study-related activities. For children and adolescents up to the age of 17 written informed consent was obtained from a parent or guardian and the child/adolescent provided written assent.
: Not applicable.
: RA, KB, CM, AT and JS were all employees of Adelphi Values at the time the research was conducted, and Adelphi Values was contracted by RB to perform the research. TS is an employee of RB. HA was a paid consultant of RB.